The possible interference of acetaminophen, combined with antibiotics, in the treatment of acute otitis media (AOM) caused by a penicillin-resistant (minimal inhibitory concentration [MIC], 2 g/mL), amoxicillin/clavulanic acid-and erythromycin-sensitive pneumococcus was evaluated in a gerbil model. Animals were challenged with 5 ϫ 10 6 bacteria in each ear through transbullar instillation. Acetaminophen was administered s.c. at 50 mg/kg 30 min before each antibiotic dose. Amoxicillin/clavulanic acid and erythromycin (2.5 and 10 mg/ kg) were administered s.c. at 2, 10, and 18 h after inoculation. Samples were obtained from the middle ear (ME) on day 2 after inoculation for bacterial count. The overall results showed no difference between animals that received acetaminophen, with or without antibiotics, and those that did not receive acetaminophen. The antibiotic concentrations in the ME were practically identical in both groups of animals, so acetaminophen did not interfere with the pharmacokinetics of antibiotics in the ME. However, both antibiotics significantly reduced the number of culture-positive and the bacterial concentration in ME samples when compared with antibiotic-untreated animals. Both antibiotics, whether combined with acetaminophen or not, lowered the number of AOM to Ͻ25%, but Ͼ75% of animals presented otitis media with effusion, and no differences were shown between groups. A high rate of bacterial eradication from the ME correlated with antibiotic serum concentrations being over the MIC of the infecting organism for only Ͼ15% of the dose interval and with an ME concentration exceeding the MIC by a factor of 1.7. In this experimental model, acetaminophen had neither a synergistic nor an antagonistic effect on the antibiotics tested. Abbreviations AOM, acute otitis media BHIE, brain-heart infusion broth enriched with 5% horse serum C 15 min, concentration at 15 min after antibiotic administration CFU, colony-forming units MBC, minimal bactericidal concentration ME, middle ear MEF, middle ear fluid without washing MEWF, middle ear washing fluid MIC, minimal inhibitory concentration MIC 50 , minimal concentration inhibiting 50% of the strains tested MIC 90 , minimal concentration inhibiting 90% of the strains tested OME, otitis media with effusion Acute otitis media (AOM) is one of the most frequently diagnosed infectious diseases of childhood, and the number of office visits for this pathology is increasing in many countries (1). One of the most common approaches to treating AOM in children is to administer an antibiotic to eradicate the pathogen, as well as an anti-inflammatory or analgesic drug such as acetaminophen (2, 3). Anti-inflammatory activity is mainly exerted through the inhibition of COX-1 and COX-2 isoenzymes that catalyze the rate-limiting step of prostaglandin synthesis (4). Recent data suggest that the little antiinflammatory activity of acetaminophen is due to its activity against COX-3 (that shows Ͻ20% activity of COX-1 and COX-2 and is present at approximately 25% of the level of COX-1) (4). However, other agents to which COX-1, COX-2, 
Acute otitis media (AOM) is one of the most frequently diagnosed infectious diseases of childhood, and the number of office visits for this pathology is increasing in many countries (1) . One of the most common approaches to treating AOM in children is to administer an antibiotic to eradicate the pathogen, as well as an anti-inflammatory or analgesic drug such as acetaminophen (2, 3) . Anti-inflammatory activity is mainly exerted through the inhibition of COX-1 and COX-2 isoenzymes that catalyze the rate-limiting step of prostaglandin synthesis (4) . Recent data suggest that the little antiinflammatory activity of acetaminophen is due to its activity against COX-3 (that shows Ͻ20% activity of COX-1 and COX-2 and is present at approximately 25% of the level of COX-1) (4). However, other agents to which COX-1, COX-2, and COX-3 are sensitive as ibuprofen (4) , given at low doses for antipyresis, have shown to be proinflammatory (increasing neutrophil influx and cytokine levels) to a level that may have adverse clinical translations in Streptococcus pneumoniae infections (5) .
The organisms most frequently involved in AOM are S. pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis; therefore, antibiotics active in vitro against these bacteria are recommended (6) . Amoxicillin/clavulanic acid is active against all three organisms and is one of the most frequently prescribed antimicrobial drugs in Spain (7) . In countries where macrolide-resistant pneumococci are not prevalent, erythromycin or the new macrolides are also recommended (6, 8) . Although most antibiotic treatments usually resolve the AOM, up to 70% of children develop otitis media with effusion (OME) (9, 10) . The reason for this complication is not known, but some antibiotics may, by inducing a rapid bacterial lysis, contribute to an inflammatory response that could be responsible for the discharge (11) .
The aim of this work was, first, to determine the possible interference of acetaminophen, combined with antibiotics, in the clinical and bacteriologic efficacy in AOM, in the antibiotic pharmacokinetic parameters, and in the development of OME. The second objective of this study was to find out whether antibiotics with different mechanisms of action and immunomodulatory properties (a ␤-lactam and a macrolide) induce, after clearing the pathogen, different rates of OME.
METHODS

Bacteria.
A strain of S. pneumoniae serotype 23 F (minimal inhibitory concentration [MIC] for benzylpenicillin ϭ 2 g/ mL) isolated from a bacteremic patient was used.
Pharmacologic compounds. Propacetamol chlorohydrate (Pro-efferalgan), a pro-drug of acetaminophen, was purchased from Upsa Laboratories (Agent-Lot et Garonne, France). Amoxicillin trihydrate, lithium clavulanate (SmithKline Beecham Pharmaceuticals, Worthing, England), and erythromycin (Sigma Chemical Co., St. Louis, MO, U.S.A.) were used for in vitro studies. For in vivo (therapeutic) use, the contents of commercial vials [Augmentin: amoxicillin/clavulanic acid, 5/1 (SmithKline Beecham S.A., Toledo, Spain) and Pantomicina: erythromycin lactobionate (Abbott Laboratories, S.A., Madrid, Spain)] were reconstituted in nonpyrogenic sterile distilled water to the desired concentrations.
In vitro studies. MICs and minimal bactericidal concentrations (MBCs) were determined by a microdilution broth method following National Committee for Clinical Laboratory Standards procedures (12, 13) . The median of three separate determinations was used as the MIC and MBC values of each antibiotic.
Animals. Eight-to 9-wk-old adult female Mongolian gerbils (Meriones unguiculatus) that weighed 49 Ϯ 5 g each were purchased from the Center d'Élevage R. Janvier (Le Genest, St. Isle, France). They were given free access to food and water and were housed in a protected unit with a slight negative pressure and with a 12-h light and 12-h dark cycle. For invasive procedures, animals were anesthetized with 50 mg/kg body wt ketamine (Ketolar; Parke-Davis, Barcelona, Spain) and 13 mg/kg of xylazine (Rompun; Bayer, Leverkusen, Germany) by intramuscular route.
The study was performed in accordance with prevailing regulations regarding the care and use of laboratory animals in the European Community (14) and approved by the Review Board for Animal Experimentation of Fundación Jiménez Díaz.
Experimental otitis. On the day of experimentation, S. pneumoniae was incubated for 4 h at 35°C in a 5% CO 2 atmosphere in brain-heart infusion broth (Oxoid, Ltd, Basingstoke, Hampshire, England) enriched with 5% horse serum (BHIE; bioMérieux, Marcy-L'Étoile, France). Animals were inoculated bilaterally, as previously reported (15), with~5 ϫ 10 6 CFU of S. pneumoniae per 20 L, which was introduced directly in the middle ear (ME) bulla. The number of viable bacteria in the different inocula was determined by colony counting. The tympanic membrane was left intact and swelled without rupture during the inoculation. A normal tympanic aspect and correct inoculation were verified by an otolaryngologist by direct otomicroscopy using an operating microscope. AOM was defined as otorrhea through a perforation in the tympanic membrane and/or inflammatory signs with changes in the membrane's normal yellowish-pink appearance to a gray, dark brownish-yellow or whitish opaque area, with a very rough surface texture. OME was defined as no inflammatory signs of tympanic membrane with air fluid levels or ME fluid with or without signs of negative ME pressure. Three animals (six ears) were inoculated with 20 L of BHIE/ear to find out the possible role of broth as inductor of otitis media. For exploring the presence of bacteremia in infected animals, blood cultures were performed in four animals 20 h after bacterial inoculation.
Treatment regimen and efficacy studies. Each antibiotic was tested at two doses (2.5 and 10 mg · kg Ϫ1 · dose Ϫ1 ) and was administered s.c. in 500 L at 2, 10, and 18 h after inoculation. Antibiotics were administered alone or combined with 50 mg/kg of propacetamol administered s.c. 30 min before each antibiotic dose, in experiments carried out in parallel. Two groups of antibiotic-untreated animals received apyrogenated sterile distilled water instead of antibiotic, one of which also received propacetamol. Groups of 12 animals per treatment and control groups were included. Treated and control animals were studied longitudinally for otorrhea, weight, and behavior. The otoscopic aspect and ME samples were obtained from both ears on day 2 after inoculation by washing the ME fossa with 20 L of saline injected and withdrawn via the epitympanic membrane with a 0.33-mm needle to determine bacterial counts in ME washing fluid (MEWF). Shortly after sampling, aliquots of serial 10-fold dilutions in saline were plated onto sheep blood agar and incubated for 24 h at 35°C in a 5% CO 2 atmosphere. Bacterial counts are expressed as log 10 croscope. The number of cells in 10 fields was calculated and expressed as mean (SD) per field.
Pharmacokinetic studies. Serum levels of acetaminophen were determined in healthy animals 15 and 30 min after s.c. administration of 50 mg/kg of propacetamol, by Fluorescence Polarization Immunoassay in an Axsym autoanalyser (Abbott Científica, Madrid, Spain). Groups of six animals per sample time were killed with CO 2 and were exsanguinated by intracardiac puncture. The limit of detection was 1 g/mL.
Serum levels of amoxicillin, clavulanic acid, and erythromycin were determined in healthy animals after a single s.c. injection of the same doses used for the treatment. Groups of six animals per dose and blood sample time (15, 30, 60 , and 120 min after drug administration) were killed as described for acetaminophen.
Antibiotic concentrations in ME fluid without washing (MEF) were also determined in groups of 10 animals bilaterally inoculated under the same conditions as previously indicated in the experimental otitis model. Single doses of 2.5 mg/kg of either antibiotic, alone and combined with propacetamol, were administered s.c. 46 h after bacterial inoculation. MEF samples were obtained 90 min later, via the epitympanic membrane, with a 0.33-mm needle. Aliquots of MEF samples having Ͼ2 L of exudate were pooled and frozen at Ϫ70°C until determination of antibiotic levels. This procedure permits collection of MEF samples at a time when effusion is consistently abundant with high bacterial density and without otorrhea.
Antibiotic concentrations were determined by microbiological assay with Micrococcus luteus ATCC 9341 and Klebsiella pneumoniae NCTC 11228. Standard curves for determination of antibiotic concentrations were obtained from standard solutions prepared in pooled gerbils' sera for serum levels and in 0.1 mol/L phosphate buffer (pH 6.0) for MEF. The variability of the assay for individual samples was Ͻ10%. Antibiotic concentration-time curves for each antimicrobial were analyzed by a noncompartmental approach using the Win-Nonlin program (Pharsight, Mountainview, CA, U.S.A.). Half-life was calculated by the expression t 1/2 ϭ (ln2)/Kel, where Kel is the apparent elimination rate constant calculated by least square regression from at least three time-point values. Statistical analysis. The number of ears with a positive count divided by the total number of ears was calculated to give the percentage of positive ears in each group of animals. For detecting differences in eradication rates in each group, the Fisher's exact test was used, with Bonferroni correction for multiple comparisons. Otorrhea at day 1 was analyzed using the 2 test and the Fisher's exact test for paired comparisons with the Bonferroni correction for multiple comparisons. Bacterial counts were expressed in untreated and treated animals as arithmetic means in log 10 CFU per 20 L of MEWF, culturenegative samples being included in the calculation of means assuming a value at the detection limit. ANCOVA was used to compare the reduction of log 10 CFU and loss of body weight at day 2 in each group controlled for the log 10 CFU or weight basal values and for the differences by groups. ANOVA was used to compare MEWF volume and polymorphonuclear leukocyte counts. When the ANCOVA or ANOVA p value was significant (p Ͻ 0.05), contrast between groups was made by use of the Tukey-Kramer test to adjust the type I experimentwise error.
RESULTS
In vitro studies. The MIC/MBC of the antibiotics (referred to as amoxicillin in the case of amoxicillin/clavulanic acid) for the pneumococcal strain used was 1/1 and 0.12/0.12 g/mL for amoxicillin and erythromycin, respectively.
Experimental otitis. Animals inoculated with BHIE showed neither clinical nor otoscopic signs of disease and at day 2; the MEWF was culture-negative. After S. pneumoniae inoculation (6.54 Ϯ 0.27 log 10 CFU), bilateral AOM was obtained in 98% of all ears from animals that did not receive antibiotics at day 2, with 100% of culture-positive MEWF samples. Most MEWF specimens contained between 7.5 and 10.8 polymorphonuclear cells per field with intra-and extracellular organisms. Animals showed lethargy, with an important weight loss and 66.6% of otorrheic ears. There were no differences between animals that received acetaminophen and those that did not receive it. Blood cultures were positive for the organisms in three of the four inoculated animals from which blood samples were taken.
Therapeutic efficacy in experimental otitis. All animals that received antibiotics at any dose were active and showed normal behavior. Table 1 presents the comparative therapeutic results for controls and antibiotic-treated animals. Both antibiotics, at any dose, with or without acetaminophen, significantly reduced the number of culture-positive MEWF specimens and the number of organisms when compared with antibiotic-untreated animals (p Ͻ 0.001). No statistical differences were found between antibiotic-treated groups (combined or not with acetaminophen). Table 2 presents the data from the otoscopic examination, otorrhea, volume of MEWF recovered, presence of polymorphonuclear cells, and weight loss. All animals that received antibiotics had low percentages of AOM, and few had positive cultures. Most antibiotic-treated animals developed posttreatment OME, and no differences were detected between doses or antibiotics (with or without acetaminophen). All antibiotictreated animals showed lower percentages of otorrhea compared with untreated controls, although differences were significant only for both doses of amoxicillin/clavulanic acid (p Ͻ 0.05). In addition, animals treated with the high dose of amoxicillin/clavulanic acid had significantly less otorrhea than animals treated with the low dose of erythromycin (p Ͻ 0.001). The presence of otorrhea correlated directly with AOM, with no differences being shown between animals that received 915 acetaminophen and those that did not receive it. As far as the volume of MEWF is concerned, there were no differences between groups. All antibiotic-treated animals had lower amounts of polymorphonuclear cells in the MEWF compared with controls (p Ͻ 0.05), with no differences between groups. With regard to loss of body weight (as recorded on day 2), all antibiotic-treated animals lost less weight than the antibioticuntreated controls (p Ͻ 0.001) without differences being shown between groups.
Pharmacokinetic and pharmacodynamic data. Serum levels of acetaminophen after administration of 50 mg/kg were 39.6 Ϯ 8.2 g/mL and 24.7 Ϯ 4.4 g/mL at 15 and 30 min, respectively. Table 3 presents the serum and MEF (with or without acetaminophen) pharmacokinetic data for amoxicillin/ clavulanic acid and erythromycin. Serum half-lives for amoxicillin/clavulanic acid were shorter than for erythromycin. ME antibiotic concentrations were lower for erythromycin than for amoxicillin/clavulanic acid. Nevertheless, penetration of amoxicillin/clavulanic acid (approximately 31/25%) was lower than that of erythromycin (approximately 53%) in relation to serum concentrations at 15 min. The administration of acetaminophen in addition to the 2.5 mg/kg dose of either amoxicillin/clavulanic acid or erythromycin did not influence the antibiotic concentration in the ME (as compared with animals that received only antibiotic). Table 4 presents the pharmacodynamic analysis in relation to the organism inoculated and the percentage of bacterial eradication. Serum inhibitory quotients (C 15 min /MIC) were Ͼ5 and time above MIC Ͼ70 min (i.e. 15-25% of the dose interval) for both antibiotics, and these values correlated with bacterial eradication (Ͼ83%). The MEF inhibitory quotients (antibiotic concentration in the MEF/MIC) for the lower doses of both antibiotics were higher than 1.
DISCUSSION
For the present study, we selected a penicillin-resistant, erythromycin-sensitive pneumococcal strain serotype 23F, because these characteristics are representative of the strains commonly found to be responsible for AOM in children (7, (17), although significantly higher erythromycin resistance prevalence is found in patients with otitis (47%), with an MIC 90 Ͼ64 g/mL as a result of the prevalence of the MLS B constitutive phenotype (17) . Low antibiotic doses were chosen to obtain in gerbils serum levels similar to those obtained in children after standard oral doses of both antibiotics (18) . For investigating whether higher doses could induce different rates of OME, a second regimen of each antibiotic was also used, so as to attain in gerbils serum concentrations similar to those attainable in children treated with high doses (18 -20) .
Amoxicillin/clavulanic acid and erythromycin both were efficacious, at any dose, in eradicating this penicillin-resistant, erythromycin-sensitive pneumococcus from the ME and in avoiding the occurrence of AOM as compared with controls. In addition, antibiotic-treated animals were active and had low loss of body weight as compared with controls. Such efficacy was obtained with antibiotic serum concentrations exceeding the MIC of the pathogen by Ͼ70 min (i.e. from 15% to 25% of the dosing interval), a value lower than that previously suggested (21) . However, these data corroborated the results obtained by our group in a previous animal model of AOM caused by penicillin-resistant pneumococci treated with low doses of amoxicillin (22) . The concentrations of both amoxicillin/clavulanic acid and erythromycin in the ME, as well as the percentages of penetration, were very similar to rates reported in children with AOM (18 -20) . The inhibitory quotient, calculated taking into account the ME concentrations (antibiotic concentration in MEF/MIC) was Ͼ1.6, thus indicating that the antibiotic concentration in the infectious foci was higher than the MIC of the offending penicillin-resistant, erythromycin-sensitive pneumococcus. In this study, as has been demonstrated previously (23) , the main pharmacodynamic parameter predicting antibiotic efficacy in otitis media is the MEF inhibitory quotient. Clinical and bacteriologic success was obtained when the antibiotic concentration in the MEF exceeded the MIC of the pathogen, which may, to some extent, be independent of serum levels (23, 24) .
Most animals treated with antibiotics developed OME, regardless of whether they were treated with amoxicillin/ clavulanic acid or with erythromycin. The immunomodulatory effect of erythromycin is well known (25, 26) , and because its mechanism of action is different from that of ␤-lactam antibiotics, macrolides could induce a lower inflammatory response than ␤-lactams do (27) (28) (29) . The hypothesis of this study was that such differences could affect the rate of OME, but it has not been corroborated in this experimental study, as had occurred in a previous study carried out using clarithromycin in the chinchilla model (30) .
The administration of acetaminophen concomitantly with either amoxicillin/clavulanic acid or erythromycin did not affect the antibiotic concentration in the ME; therefore, we did not study the possible interference in serum pharmacokinetics. Some pharmacokinetic interactions between antibiotics and nonsteroidal anti-inflammatory or antipyretic drugs have been described in experimental models but very rarely in humans (31) (32) (33) . Carsenti-Etesse et al. (34) reported some interference of acetaminophen in the bactericidal activity of cefixime against S. pneumoniae. In our experimental model, no significant differences were found in clinical, otoscopic, or bacteriologic parameters between antibiotic-untreated animals that 917 received acetaminophen and those that did not receive it, and this could be related to the weak anti-inflammatory activity of the compound (35) . Furthermore, there were no significant differences in antibiotic efficacy between animals that did and did not receive acetaminophen. Nevertheless, this may be a power issue because in the lower erythromycin dose group, worse rates (without significant statistical differences) are found in the presence of acetaminophen (16.7% versus 4.2%), and the only failure obtained with the low dose of amoxicillin/ clavulanic acid received acetaminophen concomitantly. At higher doses, antimicrobial effects may be too potent to detect any possible interference. Further studies are warranted because low doses are not uncommon as a result of poor compliance or to a decreased susceptibility of the infecting organism. In addition, acetaminophen did not prevent the appearance of OME, suggesting that no clear benefit may be expected from combining antibiotics with acetaminophen. Nonetheless, because acetaminophen may alleviate ear pain and decrease body temperature (35) , its use, alone or combined with an antibiotic, may be advocated.
